Yi-Zhun Zhu Selected Research

Yi-Zhun Zhu Research Topics

Disease

10	Myocardial Infarction 02/2022 - 08/2006
8	Inflammation (Inflammations) 01/2023 - 08/2017
8	Infarction (Infarctions) 01/2019 - 11/2005
7	Hypoxia (Hypoxemia) 01/2024 - 07/2009
7	Neoplasms (Cancer) 08/2017 - 01/2005
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2015
5	Alzheimer Disease (Alzheimer's Disease) 08/2015 - 01/2011
4	Fibrosis (Cirrhosis) 02/2020 - 10/2007
4	Hypertension (High Blood Pressure) 01/2015 - 08/2006
4	Body Weight (Weight, Body) 10/2011 - 06/2005
3	Ischemia 01/2022 - 01/2010
3	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 06/2005
3	Atherosclerosis 01/2020 - 08/2006
3	Ischemic Stroke 01/2019 - 08/2015
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2019 - 11/2005
3	Parkinson Disease (Parkinson's Disease) 01/2017 - 01/2011
3	Cognitive Dysfunction 08/2014 - 07/2010
3	Breast Neoplasms (Breast Cancer) 01/2006 - 01/2005
2	Cardiomegaly (Heart Hypertrophy) 01/2022 - 12/2003
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2013
2	Endometriosis 01/2022 - 01/2022
2	Immune System Diseases (Immune Disorders) 01/2022 - 02/2017
2	Necrosis 12/2021 - 01/2005
2	Rheumatoid Arthritis 01/2021 - 01/2016
2	Pathologic Processes 02/2020 - 01/2017
2	Brain Diseases (Brain Disorder) 01/2019 - 01/2017
2	Neuroinflammatory Diseases 10/2017 - 01/2011
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 01/2011
2	Heart Failure 01/2015 - 08/2006
2	Hypertrophy 10/2007 - 10/2003
2	Diarrhea 10/2006 - 10/2006
1	Osteoarthritis 01/2023
1	Carcinogenesis 01/2022
1	Edema (Dropsy) 01/2022
1	Gallstones (Gallstone) 12/2021
1	Metabolic Diseases (Metabolic Disease) 12/2021
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 12/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 10/2020
1	Diabetes Mellitus 10/2020
1	Alcoholic Fatty Liver 01/2020
1	Liver Diseases (Liver Disease) 01/2020
1	Rupture 01/2020
1	Atherosclerotic Plaque (Atheroma) 01/2020
1	Huntington Disease (Huntington's Disease) 01/2017
1	Reperfusion Injury 01/2017

Drug/Important Bio-Agent (IBA)

13	leonurineIBA 01/2022 - 07/2009
11	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 02/2022 - 07/2010
8	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2005
6	AntioxidantsIBA 01/2024 - 07/2009
5	sodium bisulfide (NaHS)IBA 01/2022 - 10/2007
4	CytokinesIBA 01/2023 - 10/2006
4	EnzymesIBA 10/2016 - 01/2005
4	Irinotecan (Camptosar)FDA LinkGeneric 10/2006 - 06/2005
3	LipopolysaccharidesIBA 10/2017 - 07/2010
3	Neuroprotective AgentsIBA 08/2015 - 11/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2014 - 08/2013
3	Cysteine (L-Cysteine)FDA Link 01/2013 - 05/2010
3	multidrug resistance-associated protein 1IBA 01/2006 - 01/2005
2	rhodiolosideIBA 01/2024 - 01/2010
2	Interleukin-6 (Interleukin 6)IBA 01/2024 - 10/2006
2	IntegrinsIBA 02/2022 - 03/2016
2	Estrogens (Estrogen)FDA Link 01/2022 - 01/2022
2	CollagenIBA 01/2020 - 01/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2017 - 10/2006
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2006 - 11/2005
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2006 - 11/2005
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Hyaluronic Acid (Hyaluronan)IBA 01/2023
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2022
1	Atrial Natriuretic Factor (ANF)IBA 01/2022
1	Progesterone FDA LinkGeneric 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Bile Acids and Salts (Bile Acids)IBA 12/2021
1	Atorvastatin (Lipitor)FDA Link 01/2021
1	ErbB Receptors (EGF Receptor)IBA 10/2020
1	Streptozocin (Streptozotocin)FDA Link 10/2020
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 02/2020
1	Silybin (Lagosa)IBA 01/2020
1	tangeretinIBA 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	ApolipoproteinsIBA 01/2020
1	LipidsIBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	GasesIBA 01/2018
1	matairesinolIBA 10/2017
1	Protective AgentsIBA 08/2017
1	LignansIBA 08/2017
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 02/2017
1	Sulfides (Thioethers)IBA 02/2017
1	hederageninIBA 01/2017
1	Protein AggregatesIBA 01/2017
1	Ion Channels (Ion Channel)IBA 01/2017
1	Therapeutic UsesIBA 01/2017
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2017

Therapy/Procedure

7	Therapeutics 01/2017 - 01/2005
3	Ligation 01/2019 - 07/2009
3	Drug Therapy (Chemotherapy) 10/2006 - 01/2005